Jeito Capital Strengthens Its Support in Pulmocide with Participation in $52 Million Financing
Paris, France, Dec. 6 (Korea Bizwire) - Jeito Capital (“Jeito”), the largest fully independent international private equity firm dedicated to healthcare and biopharma, announced today its participation in a $52 million Series C extension financing round in portfolio company Pulmocide, a late-stage biopharmaceutical company developing novel inhaled therapies for patients suffering from serious acute and chronic respiratory [...]